These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12680162)

  • 41. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
    Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
    In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of angiogenesis markers with lymph node metastasis in early colorectal cancer.
    Iddings DM; Koda EA; Grewal SS; Parker R; Saha S; Bilchik A
    Arch Surg; 2007 Aug; 142(8):738-44; discussion 744-5. PubMed ID: 17709727
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic value of Bax, Bcl-2, p53, and TUNEL staining in patients with radically resected ampullary carcinoma.
    Santini D; Tonini G; Vecchio FM; Borzomati D; Vincenzi B; Valeri S; Antinori A; Castri F; Coppola R; Magistrelli P; Nuzzo G; Picciocchi A
    J Clin Pathol; 2005 Feb; 58(2):159-65. PubMed ID: 15677536
    [TBL] [Abstract][Full Text] [Related]  

  • 44. mRNA and protein expression of PUMA in sporadic colorectal cancer.
    Jansson A; Arbman G; Sun XF
    Oncol Rep; 2004 Dec; 12(6):1245-9. PubMed ID: 15547745
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma.
    Ferrari S; Bertoni F; Zanella L; Setola E; Bacchini P; Alberghini M; Versari M; Bacci G
    Cancer; 2004 May; 100(9):1936-42. PubMed ID: 15112275
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma.
    Magistrelli P; Coppola R; Tonini G; Vincenzi B; Santini D; Borzomati D; Vecchio F; Valeri S; Castri F; Antinori A; Nuzzo G; Caraglia M; Picciocchi A
    J Cell Biochem; 2006 Jan; 97(1):98-108. PubMed ID: 16173075
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Expression of p53 protein in women with endometrial cancer].
    Ivanov S; Khadzhiolov N; Ivanov S
    Akush Ginekol (Sofiia); 2001; 40(4):14-5. PubMed ID: 11803862
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Flow cytometry expression of p53 and PCNA in oral/oropharynx carcinomas and their lymph node metastases.
    Sidari L; Tirelli G; Papanikolla L; Sasso F; Russolo M; Melato M
    Anticancer Res; 2003; 23(5b):4127-32. PubMed ID: 14666613
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bcl-2 expression is a prognostic factor in the subgroups of patients with colorectal cancer.
    Sun XF; Bartik Z; Zhang H
    Int J Oncol; 2003 Nov; 23(5):1439-43. PubMed ID: 14532988
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of maspin in colorectal cancer.
    Umekita Y; Souda M; Yoshida H
    In Vivo; 2006; 20(6B):797-800. PubMed ID: 17203770
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of the mitogen-activated protein kinase and phosphoinositide 3-kinase/AKT pathways downstream molecules, phosphorylated extracellular signal-regulated kinase, and phosphorylated AKT in colorectal cancer-a tissue microarray-based approach.
    Lugli A; Zlobec I; Minoo P; Baker K; Tornillo L; Terracciano L; Jass JR
    Hum Pathol; 2006 Aug; 37(8):1022-31. PubMed ID: 16867865
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationships of P53 and Bak with EPO and EPOR in human colorectal cancer.
    Baltaziak M; Koda M; Wincewicz A; Sulkowska M; Kanczuga-Koda L; Sulkowski S
    Anticancer Res; 2009 Oct; 29(10):4151-6. PubMed ID: 19846965
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systematic assessment of protein phenotypes characterizing high-grade tumour budding in mismatch repair-proficient colorectal cancer.
    Karamitopoulou E; Lugli A; Panayiotides I; Karakitsos P; Peros G; Rallis G; Patsouris ES; Terracciano L; Zlobec I
    Histopathology; 2010 Aug; 57(2):233-43. PubMed ID: 20716165
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The expression of tumorigenesis markers in oral papilloma.
    Reszeć J; Sulkowska M; Famulski W; Guzińska-Ustymowicz K; Sulkowski S
    Pol J Pathol; 2002; 53(4):195-200. PubMed ID: 12597336
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bcl-2 expression in colorectal tumours. Correlation with p53, mdm-2, Rb proteins and proliferation indices.
    Goussia AC; Ioachim E; Agnantis NJ; Mahera M; Tsianos EV
    Histol Histopathol; 2000 Jul; 15(3):667-72. PubMed ID: 10963109
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cellular protein alterations in colorectal cancer: p28, p53 and p65 studies.
    Stawińska M; Bryś M; Kiliańska ZM; Hanausek-Wataszek M; Krajewska WM
    Cytobios; 2001; 106 Suppl 1():43-55. PubMed ID: 11534828
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic dissimilarity between primary colorectal carcinomas and their lymph node metastases: ploidy, p53, bcl-2, and c-myc expression--a pilot study.
    Zalata KR; Elshal MF; Foda AA; Shoma A
    Tumour Biol; 2015 Aug; 36(8):6579-84. PubMed ID: 25840688
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expressions of latent membrane protein 1, p53 and bcl-2 proteins and their significance in Hodgkin's lymphoma.
    Qi ZL; Zhao T; Zhou XH; Zhang JH; Han XQ; Zhu MG
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Mar; 23(3):225-7. PubMed ID: 12651235
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nup88 mRNA overexpression in colorectal cancers and relationship with p53.
    Zhao ZR; Zhang ZY; He XQ; Hu YM; Tian YF; Zhang LJ; Sun XF
    Cancer Biomark; 2010-2011; 8(2):73-80. PubMed ID: 21896994
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic evaluation of CD44 expression in correlation with bcl-2 and p53 in colorectal cancer.
    Zavrides HN; Zizi-Sermpetzoglou A; Panousopoulos D; Athanasas G; Elemenoglou I; Peros G
    Folia Histochem Cytobiol; 2005; 43(1):31-6. PubMed ID: 15871560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.